Skip to main content
Figure 2 | Clinical and Translational Allergy

Figure 2

From: The impact of structural integrity and route of administration on the antibody specificity against three cow’s milk allergens - a study in Brown Norway rats

Figure 2

Immunogenicity and sensitising capacity of the cow’s milk proteins. The titre levels of the specific antibodies raised in rats dosed i.p. or orally with cow’s milk proteins. (A) BLG (), ALA (■) or β-casein (▲)-specific IgG1 responses for rats immunised i.p. three times at an interval of 14 days with either BLG, ALA and β-casein, respectively, without the use of adjuvant. (B) BLG (), ALA (■) and β-casein (▲)-specific IgG1 responses for rats dosed orally by SMP each day for seven weeks without the use of adjuvant. (C) BLG (), ALA (■) and β-casein (▲)-specific IgE responses for rats immunised i.p. three times at an interval of 14 days with either BLG, ALA or β-casein without the use of adjuvant. (D) BLG (), ALA (■) and β-casein (▲)-specific IgE responses for rats dosed orally by SMP each day for seven weeks without the use of adjuvant.

Back to article page